# Tracking Triple-negative Breast Cancer Evolution Through Therapy

> **NCT03077776** · NA · ACTIVE_NOT_RECRUITING · sponsor: **UNICANCER** · enrollment: 149 (actual)

## Conditions studied

- Triple-Negative Breast Neoplasm

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Biopsy (optional)
- **PROCEDURE:** Biopsy (metastatic)

## Key facts

- **NCT ID:** NCT03077776
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-14
- **Primary completion:** 2024-06-01
- **Final completion:** 2026-05
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2025-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03077776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03077776, "Tracking Triple-negative Breast Cancer Evolution Through Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03077776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*